Compare Palo Alto Networks Inc (PANW) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Palo Alto Networks Inc vs Tenet Healthcare Corporation — how do they compare? Palo Alto Networks Inc trades at $401 (market cap $331.76B), while Tenet Healthcare Corporation trades at $260 (market cap $20.92B). The key difference: Palo Alto Networks Inc is far larger — about 15.9× Tenet Healthcare Corporation's market cap, and Palo Alto Networks Inc is trading nearer its 52-week high, Tenet Healthcare Corporation nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Palo Alto Networks Inc for 82 Days and Tenet Healthcare Corporation for 15 Days on average.
| PANW | THC | |
|---|---|---|
Market Cap | $331.76B | $20.92B |
Volume | 3,886,927 | 455,764 |
Sector | Technology | Health |
52-Week High | $419.91 | $280.77 |
52-Week Low | $141.67 | $161.37 |
Typical Hold Time | 82 Days | 15 Days |
Enterprise Value | $331.19B | $32.00B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Palo Alto Networks (PANW) trades at $398.50, down 5.1% today but remains near its 52-week high. The stock shows strong technical momentum with bullish moving averages and positive analyst sentiment (72% buy ratings). Recent earnings beats and robust revenue growth to $9.22B in 2025 highlight fundamental strength, though valuation metrics appear elevated with P/E at 1,013.93 and P/S at 26.99. The company's AI-driven security platform and continuous defense services are driving market optimism.
Outlook remains positive given cybersecurity demand and AI integration, but premium valuation and rising costs pose risks. Revenue growth acceleration to $11.5B projected for 2026 supports bullish case, while net margin compression to 2.67% warrants monitoring. Analyst consensus target of $398.70 suggests limited near-term upside from current levels.
Tenet Healthcare (THC) trades at $259.83, up 0.53% with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with consistent earnings beats (Q4 2025-Q2 2026), 82.83% gross margins, and 53.31% ROE. Recent news highlights strong cash flow supporting capital returns, with Q3 2026 results expected October 29, 2026.
THC presents compelling value with a 10.04 P/E ratio and 81.25% analyst buy ratings. Upside potential to $283.36 consensus target exists, though negative cash flow trends and insider selling warrant monitoring. The stock's premium valuation (P/B 4.49) requires sustained execution amid healthcare sector volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Palo Alto Networks Inc
Palo Alto Networks is a pure-play cybersecurity vendor that sells security appliances, subscriptions, and support into enterprises, government entities, and service providers. The company's product portfolio includes firewall appliances, virtual firewalls, endpoint protection, cloud security, and cybersecurity analytics. The Santa Clara, California, firm was established in 2005 and sells its products worldwide.
Read more on PANW →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
